Cor Vasa 2006, 48(7-8):289-291

Cardiac surgery in patients with hematologic malignancies

Jiří Novosad^1,*, Libuše Novosadová², Věra Farbiaková³, Karel Srovnalík⁴, Piotr Branny¹

¹ Kardiochirurgické oddělení, Nemocnice Třinec-Podlesí a. s.

² Hematologické oddělení, Nemocnice s poliklinikou, Havířov

³ Hematologicko-transfuzní oddělení, Nemocnice s poliklinikou, Třinec-Sosna

⁴ Hematologicko-transfuzní oddělení, Nemocnice s poliklinikou, Vsetín, Česká republika

Development of cardiac surgery over the last decade has made it possible to operate even on patients with serious comorbidities. In addition, the expanding body of experience of cardiac surgery departments has resulted in extended average life expectancy of patients undergoing cardiac surgery. The paper addresses the issue of patients with hematologic malignancies, who had open-heart surgery in our department. Generally, these patients are immunocompromised and, consequently, at increased risk of infections. Moreover, they often have coagulation disorders, taking the form of either an increased tendency to bleeding in some patients or hypercoagulation in others. From 2004 through 2005, 12 patients with hematologic malignancies underwent open-heart surgery. While the 30-day mortality was zero, our patients had an increase in postoperative morbidity as expected.

Keywords: Hematologic malignancies; Open-heart surgery; Complications; Surgical benefit

Published: July 1, 2006  Show citation